Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study

by Andersen, Kasper, Rasmussen, Finn, Held, Claes, Neovius, Martin, Tynelius, Per, Sundström, Johan
Published 2015

Treatment of depression and anxiety with internet-based cognitive behavior therapy in patients with a recent myocardial infarction (U-CARE Heart): study protocol for a randomized c...

by Norlund, Fredrika, Olsson, Erik MG, Burell, Gunilla, Wallin, Emma, Held, Claes
Published 2015

Physical activity in patients with stable coronary heart disease: an international perspective

by Stewart, Ralph, Held, Claes, Brown, Rebekkah, Vedin, Ola, Hagstrom, Emil, Lonn, Eva, Armstrong, Paul, Granger, Christopher B., Hochman, Judith, Davies, Richard, Soffer, Joseph, Wallentin, Lars, White, Harvey
Published 2013

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

by Storey, Robert F., James, Stefan K., Siegbahn, Agneta, Varenhorst, Christoph, Held, Claes, Ycas, Joseph, Husted, Steen E., Cannon, Christopher P., Becker, Richard C., Steg, Ph Gabriel, Åsenblad, Nils, Wallentin, Lars
Published 2014

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

by Halvorsen, Sigrun, Atar, Dan, Yang, Hongqiu, De Caterina, Raffaele, Erol, Cetin, Garcia, David, Granger, Christopher B., Hanna, Michael, Held, Claes, Husted, Steen, Hylek, Elaine M., Jansky, Petr, Lopes, Renato D., Ruzyllo, Witold, Thomas, Laine, Wallentin, Lars
Published 2014

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

by Hijazi, Ziad, Lindbäck, Johan, Alexander, John H., Hanna, Michael, Held, Claes, Hylek, Elaine M., Lopes, Renato D., Oldgren, Jonas, Siegbahn, Agneta, Stewart, Ralph A.H., White, Harvey D., Granger, Christopher B., Wallentin, Lars
Published 2016

Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease

by Stewart, Ralph A. H., Wallentin, Lars, Benatar, Jocelyne, Danchin, Nicolas, Hagström, Emil, Held, Claes, Husted, Steen, Lonn, Eva, Stebbins, Amanda, Chiswell, Karen, Vedin, Ola, Watson, David, White, Harvey D.
Published 2016

Efficacy and Safety of Vorapaxar in Non–ST‐Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

by van Diepen, Sean, Tricoci, Pierluigi, Podder, Mohua, Westerhout, Cynthia M., Aylward, Philip E., Held, Claes, Van de Werf, Frans, Strony, John, Wallentin, Lars, Moliterno, David J., White, Harvey D., Mahaffey, Kenneth W., Harrington, Robert A., Armstrong, Paul W.
Published 2015

Lipoprotein‐Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

by Wallentin, Lars, Held, Claes, Armstrong, Paul W., Cannon, Christopher P., Davies, Richard Y., Granger, Christopher B., Hagström, Emil, Harrington, Robert A., Hochman, Judith S., Koenig, Wolfgang, Krug‐Gourley, Sue, Mohler, Emile R., Siegbahn, Agneta, Tarka, Elizabeth, Steg, Philippe Gabriel, Stewart, Ralph A. H., Weiss, Robert, Östlund, Ollie, White, Harvey D., Budaj, Andrzej, Ardissino, Diego, Avezum, Alvaro, Aylward, Philip E., Bryce, Alfonso, Chen, Hong, Chen, Ming‐Fong, Corbalan, Ramon, Dalby, Anthony J., Danchin, Nicolas, De Winter, Robbert J., Denchev, Stefan, Diaz, Rafael, Elisaf, Moses, Flather, Marcus D., Goudev, Assen R., Grinfeld, Liliana, Husted, Steen, Kim, Hyo‐Soo, Linhart, Ales, Lonn, Eva, López‐Sendón, José, Manolis, Athanasios J., Nicolau, José C., Pais, Prem, Parkhomenko, Alexander, Pedersen, Terje R., Pella, Daniel, Ramos‐Corrales, Marco A., Ruda, Mikhail, Sereg, Mátyás, Siddique, Saulat, Sinnaeve, Peter, Sritara, Piyamitr, Swart, Henk P., Sy, Rody G., Teramoto, Tamio, Tse, Hung‐Fat, Weaver, W. Douglas, Viigimaa, Margus, Vinereanu, Dragos, Zhu, Junren
Published 2016